Description
Summary Information: GLUCOPHAGE 850 mg is a medication containing the active substance Metformin Hydrochloride. Each tablet typically contains 850 mg of Metformin Hydrochloride. GLUCOPHAGE is primarily used in the management of type 2 diabetes mellitus, helping to control blood sugar levels and improve insulin sensitivity. Metformin Hydrochloride belongs to the class of medications known as biguanides, which work by reducing glucose production in the liver, increasing insulin sensitivity in peripheral tissues, and improving glucose uptake by muscles.
Product Composition: The active pharmaceutical ingredient in GLUCOPHAGE 850 mg tablets is Metformin Hydrochloride. Metformin Hydrochloride acts by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity in peripheral tissues, leading to better glucose utilization and control. In addition to Metformin Hydrochloride, GLUCOPHAGE tablets may contain various excipients and coatings to ensure proper formulation and stability.
Manufacturer: GLUCOPHAGE 850 mg tablets are manufactured by Merck, a multinational pharmaceutical company known for its commitment to providing high-quality medications and innovative healthcare solutions. Merck ensures product efficacy, safety, and compliance with regulatory standards.
Package: GLUCOPHAGE 850 mg tablets are typically supplied in packs containing multiple tablets, each with a dosage strength of 850 mg of Metformin Hydrochloride. The packaging may include information such as the expiration date, lot number, and manufacturer details.
Usage Instructions: GLUCOPHAGE 850 mg tablets are taken orally with water, usually once or twice daily, or as directed by a healthcare professional. The dosage and administration schedule may vary depending on factors such as the patient’s medical condition, response to treatment, and concurrent use of other antidiabetic medications. It is essential to follow the prescribed regimen closely and not to exceed recommended dosages without medical supervision.
Benefits:
- Blood Sugar Control: GLUCOPHAGE helps improve glycemic control by reducing blood sugar levels, decreasing insulin resistance, and enhancing glucose uptake by peripheral tissues.
- Weight Management: Metformin Hydrochloride is associated with modest weight loss or prevention of weight gain, making it suitable for overweight or obese patients with type 2 diabetes.
- Cardiovascular Protection: GLUCOPHAGE therapy has been shown to reduce the risk of cardiovascular events and improve cardiovascular outcomes in patients with type 2 diabetes.
- Minimal Hypoglycemia Risk: GLUCOPHAGE is associated with a low risk of hypoglycemia when used as monotherapy or in combination with other antidiabetic agents, making it suitable for long-term diabetes management.
It is important to note that GLUCOPHAGE should only be used under the supervision of a qualified healthcare professional experienced in the management of diabetes. Patients should be monitored regularly for treatment response, blood sugar levels, and potential adverse effects, and appropriate adjustments to dosage or treatment regimen should be made as needed.
Reviews
There are no reviews yet.